- In March 2025, The Alliance for Genomic Discovery announced the completion of sequencing 250,000 whole genomes. This milestone aims to accelerate drug discovery and enhance the understanding of genetic variations associated with various diseases
- In September 2024, Variantyx introduced Genomic Unity 2.0, an advanced whole-genome diagnostic test that integrates long-read and short-read sequencing technologies. This innovation aims to provide comprehensive genetic analysis, enhancing diagnostic accuracy and patient care
- In August 2023, London-based biotech company Genomes.io raised Pound 18 million in a funding round led by GEM Digital Limited. The investment is intended to accelerate the company's technological growth and expand the use of its genomic data vault and reporting products, focusing on the secure and private monetization of genomic data
- In May 2022, Gencove partnered with NEOGEN Corporation to introduce InfiniSEEK, a groundbreaking and affordable solution for whole-genome sequencing and targeted SNP analysis. This collaboration aims to advance genomic research and applications in various fields
- In March 2022, Healthcare solutions company LetsGetChecked acquired Veritas Genetics Inc. and Veritas Intercontinental, both innovators in genomics. This acquisition is part of LetsGetChecked's strategy to expand its capabilities in genetic testing and personalized healthcare services
